Trial Profile
Effect of Nighttime Valsartan on Prognosis of Nocturnal Hypertension Patients Undergoing Maintenance Hemodialysis
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms NVHH
- 26 Jul 2018 New trial record